Evidence map›Paper›PMID 23835849›Full record

ArticleThe Journal of experimental medicine2013

CD4+ T helper cells use CD154-CD40 interactions to counteract T reg cell-mediated suppression of CD8+ T cell responses to influenza.

André Ballesteros-Tato, Beatriz León, Frances E Lund, Troy D Randall

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. TScience advances · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. CD4Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Article
  12. The opposing roles of CD4Immunology · 2018
    Review
  13. Type 1 Conventional CD103Frontiers in immunology · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

André Ballesteros-TatoDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Beatriz León
Frances E Lund
Troy D Randall
Center for Rheumatology · USUniversity of Alabama at Birmingham · US

Funding

Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI WU, HULIN · 2010 to 2014
$10.8M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Unique Aspects of Respiratory ImmunityR01HL069409 · NHLBI · UNIVERSITY OF ROCHESTER · PI RANDALL, TROY D · 2001 to 2015
$5.3M
Generation and maintenance of influenza-specific plasma and memory B cellsR01AI068056 · NIAID · UNIVERSITY OF ROCHESTER · PI LUND, FRANCES E. · 2006 to 2010
$2.3M
Generation of effective memory CD8 T cells to influenzaR01AI061511 · NIAID · UNIVERSITY OF ROCHESTER · PI RANDALL, TROY D · 2005 to 2009
$1.8M
Function of NALT in nasal immunization to heterotypic strains of influenzaR01AI072689 · NIAID · UNIVERSITY OF ROCHESTER · PI RANDALL, TROY D · 2007 to 2010
$1.5M
NHLBI NIH HHS HL069409NHLBI NIH HHS R01 HL069409NIAID NIH HHS AI061511NIAID NIH HHS AI068056NIAID NIH HHS AI072689NIAID NIH HHS AI078907NIAID NIH HHS P01 AI078907NIAID NIH HHS R01 AI061511NIAID NIH HHS R01 AI068056NIAID NIH HHS R01 AI072689NIAMS NIH HHS P30 AR048311
6 · The paper itself

Abstract

CD4(+) T cells promote CD8(+) T cell priming by licensing dendritic cells (DCs) via CD40-CD154 interactions. However, the initial requirement for CD40 signaling may be replaced by the direct activation of DCs by pathogen-derived signals. Nevertheless, CD40-CD154 interactions are often required for optimal CD8(+) T cell responses to pathogens for unknown reasons. Here we show that CD40 signaling is required to prevent the premature contraction of the influenza-specific CD8(+) T cell response. CD40 is required on DCs but not on B cells or T cells, whereas CD154 is required on CD4(+) T cells but not CD8(+) T cells, NKT cells, or DCs. Paradoxically, even though CD154-expressing CD4(+) T cells are required for robust CD8(+) T cell responses, primary CD8(+) T cell responses are apparently normal in the absence of CD4(+) T cells. We resolved this paradox by showing that the interaction of CD40-bearing DCs with CD154-expressing CD4(+) T cells precludes regulatory T cell (T reg cell)-mediated suppression and prevents premature contraction of the influenza-specific CD8(+) T cell response. Thus, CD4(+) T helper cells are not required for robust CD8(+) T cell responses to influenza when T reg cells are absent.

Indexed as

AnimalsCD40 AntigensCD40 LigandCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell CommunicationDendritic CellsEpitopesMiceMice, KnockoutNucleocapsid ProteinsOrthomyxoviridae InfectionsProtein BindingRNA-Binding ProteinsSignal TransductionT-Lymphocytes, Helper-InducerCD40 AntigensCD40 LigandEpitopesNP protein, Influenza A virusNucleocapsid ProteinsRNA-Binding ProteinsViral Core Proteins

Identifiers

PMID23835849
PMCPMC3727323
OpenAlexW2139860153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.